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Abstract 
Purpose: To evaluate the use of routine diagnostic tools among community pharmacists in Ibadan, 
Nigeria.  
Methods: This is a cross-sectional study with pre-tested questionnaire administered to 94 pharmacists 
in community pharmacies in Ibadan, southwestern Nigeria. Descriptive statistics was used to 
summarise data and categorical variables were compared with Chi-square at a significance level of p < 
0.05.  
Results: With a response rate of 94.7 %, the study showed that 78 (87.6 %) of the respondents use 
routine diagnostic tools, 48 (53.9 %) document results of routine diagnostic tests, 72 (80.9 %) make 
interventions on the results but only 37 (41.6 %) document the interventions  made. Although all the 
respondents were aware of the concept of pharmaceutical care (PC), only 55.1 % of them had adequate 
knowledge of PC, while 93.3% were willing to undergo training to improve their knowledge on PC 
implementation.  
Conclusion: Most community pharmacists routinely use diagnostic tools in Ibadan. However, there is 
need for improvement on documentation practices. 
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Point-of-care (POC) testing typically involves 
performing a robust diagnostic test that rapidly 
produces reliable results outside a laboratory at 
or near the patient to aid in disease screening, 
diagnosis, and/or patient monitoring [1-3]. It 
includes blood glucose testing, blood gas and 
electrolyte analysis, rapid coagulation testing, 
rapid diagnosis of cardiac markers, screening of 
drugs of abuse, urine strips testing, pregnancy 
tests, faecal occult blood analysis, food pathogen 
screening, hemoglobin diagnostics, infectious 
disease testing and cholesterol screening. To 
improve clinical management (e.g., triage, 
referral, and treatment decisions), such tests 
should be convenient and simple to perform, and 
should have a rapid turnaround of results. With 
POC testing, the screening or diagnostic 
processes can be completed during a single 
clinical encounter, a key difference from 
laboratory-based testing [4]. 
 
POC testing has become established worldwide 
and finds vital roles in public health [5]. These 
testing devices have been used in community 
clinic settings and pharmacies in a number of 
countries [6]. Its potential operational benefits 
include more rapid decision making and triage, 
reduced operating times, reduced emergency 
room time, reduced number of outpatient clinic 
visits, reduced emergency admissions and 
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optimal use of professional time. In South Africa, 
Flobbe et al found out that blood pressure 
measurement, and tests for serum cholesterol, 
capillary glucose and pregnancy were the most 
commonly offered services in pharmacy-based 
screening programs [12]. Screening tests were 
conducted less than five times a week, except for 
blood pressure measurement which was more 
frequent and less than half of the records kept by 
respondent pharmacies [12]. The ready 
availability of these routine diagnostic tools 
affords community pharmacists the opportunity to 
perform on-site laboratory services for patients 
[13]. Moreover, the use of routine diagnostic 
tools as a part of pharmaceutical care is 
advantageous because they require small 
samples and are convenient for patients, 
portable and allow testing in a variety of 
locations. For example, hypertensive patients 
usually check their blood pressure (BP) at 
community pharmacies [14]. Taking BP 
measurements in this setting is recommended by 
some scientific hypertension societies, such as 
those in Canada [15]. In Nigeria, there are 
indications that majority of DM patients check 
their blood glucose status only on the 
appointment days in the clinic [18]. In this 
respect, community pharmacists, who are easily 
accessible to patients, can take up the challenge 
of doing routine diagnostic tests. 
 
This study was aimed at evaluating the use of 
routine diagnostic tools among community 
pharmacists in Ibadan. In addition, it evaluated 
awareness of the respondents on pharmaceutical 
care concept as well as the documentation of 






The study was carried out in all the 11 local 
government areas in Ibadan, the capital of Oyo 
State, Nigeria. With a population of over 3 
million, Ibadan is the most populous city in the 
State, and the third most populous city in Nigeria. 
Community pharmacists in all the 94 pharmacies 
registered with the Pharmacists Council of 
Nigeria (PCN) in the 11 local governments were 
enlisted for the study. These pharmacies are 




This is a questionnaire-based cross-sectional 
study which assessed the use of routine 
diagnostic tools among all community 
pharmacists in the study location. The 
questionnaire was divided into two sections. 
Section A addressed the demographic 
information as well as basic information on 
pharmaceutical care (means of awareness, 
definition, self-rating on the knowledge, level of 
implementation and willingness to undergo 
training) while section B addressed the use of 
routine diagnostic tools, how the skills were 
acquired, frequency of use, fees charged for the 
tests and documentation of results. The 
questionnaire was pre-tested among 5 
community pharmacists; the results from the pre-
test were not included in the study.  
 
Survey questionnaire was self-administered to 
the pharmacists in their respective pharmacies. 
Repeated visits were made for data collection 




Data collected were entered into a computer 
spreadsheet and analysed using descriptive 
statistics. Categorical variables were compared 





Out of the 94 pharmacists surveyed, the 
response rate was 94.7%. Most of these 
respondents (61.8%) were males. The highest 
qualification and duration of practice as 
pharmacists are as shown in Table 1. 
 
Table 1: Highest qualification and practice duration of 
the pharmacists 
 
Variable Frequency % 
Qualification 
 
B. Pharm 68 76.4 
PharmD 2 2.2 
M. Pharm/M. Sc. 12 13.5 
MBA and PGDHM 1 1.1 
MMP 1 1.1 
MBA 4 4.5 
PhD 1 1.1 
Duration of practice (years) 
1-5 45 50.6 
6-10 11 12.4 
11-15 7 7.9 
15-20 4 4.5 
> 20 22 24.7 
MMP = Master of Managerial Practice, PGDHM= 
Postgraduate Diploma in Herbal Medicine 
 
Although all the respondents were aware of 
pharmaceutical care (PC) concept, 42.7% of 
them defined PC correctly, 31.5% were partially 
correct while as many as 23 (25.8%) could not 
define the concept correctly. Majority of the 
respondents (49, 55.1%) had adequate 
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knowledge of PC, while 83 (93.3%) were willing 
to undergo training to improve their knowledge 
on PC implementation. The rating on the level of 
implementation of pharmaceutical care concept 
in the respondents’ pharmacy premises showed 
that 29 (32.6%) of the participants fully 
implemented it, 46 (51.7%) implemented it fairly-
well, 13 (14.6%) implemented it poorly, while 1 
(1.1%) did not implement it. Most of them 
(75.3%) acquired their knowledge of PC in 
pharmacy schools (Table 2). 
 
Table 2: Source of information on pharmaceutical care 
concept 
 
Information source Frequency % 
Pharmacy school 67 75.3 
Journals 7 7.9 
Postgraduate studies 2 2.2 
Internet 2 2.2 
Colleagues 2 2.2 
MCPD updates 6 6.7 
PSN seminar 1 1.1 
B.Sc. Physiology 1 1.1 
Practice 1 1.1 
MCPD = Mandatory Continuing Professional 
Development 
 
Majority of respondents used routine diagnostic 
tools in their pharmacies. These tools included 
blood pressure monitors (87.6%), glucose 
monitors (46.07%), weight scales (83.1%), and 
height scales (44.9%). In addition, majority of 
them (58.4 %) ran pregnancy tests in their 
pharmacies (Table 3). The source of acquisition 
of skill in routine use of these diagnostic tools is 
provided in Table 4 while the proportions of 
respondents who charged fees for the use of 
routine diagnostic tools are provided in Table 5. 
While majority of the respondents (80.9 %) 
reported making interventions following 
diagnostic tests in their pharmacies, only 41.6 % 




The study revealed that over 75 % of the 
respondents used routine diagnostic tools, while 
only 50 % of these documented their 
interventions. Although the community 
pharmacists were aware of PC concept, only 55 
% of them had adequate knowledge of the 
concept.  
 
Generally, the training of a pharmacist in Nigeria 
does not often include the use of routine 
diagnostic tools at the level of Bachelor of 
Pharmacy (B.Pharm.) degree curriculum. With 
the introduction of the Doctor of Pharmacy 
(PharmD) programme and developments in 
pharmacy education, the community pharmacists 
have acquired knowledge on how to use 
diagnostic tools. Incorporation of training on the 
use of these tools is mandatory in existing 
mandatory continuing education programme for 
pharmacist.  This   is   vital   for   increasing   the 














Daily 54 (60.7%) 14 (15.7%) 20 (22.5%) 45 (50.6%) 29 (32.6%) 
Twice or more  
Times/week 12 (13.5%) 10 (11.2%) 10 (12.5%) 14 (15.7%) 2 (2.2%) 
Weekly 6 (6.7%) 10 (11.2%) 12 (13.5%) 6 (6.7%) 2 (2.2%) 
Monthly 1 (1.1%) 2 (2.2%) 1 (1.1%) 1 (1.1%) 1 (1.1%) 
Rarely 4 (4.5%) 7 (7.9%) 10 (11.2%) 11 (12.4%) 8 (9.0%) 
Never 12 (13.5%) 46 (51.7%) 36 (40.4%) 12 (13.5%) 47 (52.8%) 
 
Table 4: Source of skill acquisition in the use of routine diagnostic tools by respondents 
 











BP measurement 50 (56.2%) 1 (1.1%) 38 (42.7%) - - - 
BG measurement 34 (38.2%) 1 (1.1%) 48 (53.9%) 1 (1.1%) 3 (3.4%) Industrial training 2 (2.2%) 
Pregnancy test 14 (15.7%) - 65 (73.0%) 3 (3.4%) 5 (5.6%) Industrial training 2 (2.2%) 
Weight measurement 42 (47.2%) - 43 (48.3%) - - 
Primary school 1 (1.1%) 
Secondary school 1 (1.1%) 
Industrial training 2 (2.2%) 
Height measurement 42 (47.2%) - 41 (46.1%) - 2 (2.2%) 
Primary school 1 (1.1%) 
Secondary school 1 (1.1%) 
Industrial training 2 (2.2%) 
BMI calculation 58 (65.2%) 1 (1.1%) 23 (25.8%) 3 (3.4%) 2 (2.2%) Secondary school 1 (1.1%) Industrial training 1 (1.1%) 
BP = Blood pressure; BG  =  blood glucose
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Table 5: Respondents who charged fees for routine 
diagnostic tests 
 
Routine diagnostic test Frequency 
(%) 
Blood pressure monitor (n = 77) 31 (40.3%) 
Blood glucose monitor (n = 44) 37 (84.1%) 
Pregnancy test (n = 52) 36 (69.2%) 
Weight measurement (n = 77) 9 (11.7%) 
Height measurement (n = 42) 7 (16.7%) 
 
number of pharmacists using these tools as part 
of their services to patients.  
 
Over 75 % of respondents used blood pressure 
monitors in this study. This result is similar to an 
earlier result from a study in Enugu, southeastern 
Nigeria [22]. As regards service charges for 
routine diagnostic tests, the blood glucose and 
pregnancy tests were the tests where most of the 
respondents charged fees mainly to defray cost 
of materials used. Although the documentation of 
intervention in this study is considered poor with 
even less than one-tenth employing 
computerized methods, it is comparable to earlier 
studies in Enugu [22] and Ibadan [23]. Most of 
those who documented their interventions did so 
manually. However, our study showed better 
documentation of interventions when compared 
with an earlier study in Ghana where 88 % of the 





The findings of this study reveal that a minority of 
community pharmacists in Ibadan routinely use 
diagnostic tools in their pharmacies. Moreover, 
documentation of their related interventions was 
poor. The need to improve education of 
pharmacists in provision of basic diagnostic 
services is vital considering that most patients 
often consider community pharmacies their first 
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